A64 TRIFLUOROACETATE

Stock Code: 3575319
Manufacturer Part No: SML1731-5MG
Order Now for 7 day delivery
£131.76 (exc VAT) per 5MG
Quantity: - +

Biochem/physiol Actions


A64 is a cell-permeable, ATP site-targeting pyridone thiazolidinedione compound that acts as a potent HIPK2-selective homeodomain-interacting protein kinase inhibitor (IC50 = 74 nM and 136 nM against HIPK2 and HIPK1, respectively; [ATP] = 100 µM), affecting MPF only at higher concentrations (by 35% at 5 µM; [ATP] = 10 µM) and exhibiting little potency toward CDK1 (IC50 >10 µM). A64 (1 µM) effectively prevents ER stresser tunicamycin (1 µg/mL) -induced HIPK2/JNK phosphorylation and cell death in HEK293 and primary rat motor neuron cultures. HIPK2 inhibition by A64 treatment is also efficacious in protecting rat motor neurons from death upon exogenous SOD1 G93A or TDP-43 expression. ff-target kinases revealed by kinome profiling include DYRK1A, CSNK2A2, DAPK2, DAPK1, PIM3, CSNK2A1, PIM1 (Kd = 8.8, 6.1, 6.1, 9.5, 3.7, 31, 37 nM, respectively) and DYRK1B (IC50 = 62 nM).


Packaging


5, 25 mg in glass bottle

Colourwhite to beige
Quality Level100
ManufacturerSIGMA-ALDRICH
Storage Temp.2-8°C
SolubilityH2O: 10 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.